MDXG compared with BVS: revenue, margins and what each company keeps, and the suppliers and customers both name

MDXGMimedx Group, Inc.

Mkt capRevenueRevenue

BVSBioventus Inc.

Mkt capRevenueRevenue

Compare

MDXGMimedx Group, Inc.

BVSBioventus Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MDXG

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▲+0.51%—

Q2 FY26±39.8%▲+0.95%×0.02

Q1 FY26—▲+8.91%—

Feb 26 '26±13.3%▼−6.44%×0.48

BVS

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±19.9%▲+13.71%×0.69

May 6 '26±17.1%▲+2.25%×0.13

= impliedMDXG realized, solidBVS realized, hatchedOne scale, both sides: full bar = 40%× = |realized| ÷ impliedSource: market data

Q1 FY26

±17.5%

▲+7.44%

×0.42

Nov 4 '25±18.0%▲+15.09%×0.84

MDXGMimedx Group, Inc.

3.33· pre 3.33· delayed

Mkt cap$478.6MRevenue$62MQ3 FY26Revenue$419MFY25

BVSBioventus Inc.

13.14· pre 10.50· delayed

Pre-marketNov 3 '26delayed

Mkt cap$1.1BRevenue$142MQ3 FY26Revenue$568MFY25

Compare

Pre-marketNov 3 '26delayed

MDXGMimedx Group, Inc.

BVSBioventus Inc.

3.33pre 3.33delayed

Price

13.14pre 10.50delayed

$478.6M

Mkt cap

$1.1B

Q3 FY26$62M

Revenue

$142MQ3 FY26

FY25$419M

Revenue

$568MFY25

MDXG3.33vsBVS13.14Pre-marketNov 3 '26delayed